CIK 0001604464
- Non-accelerated filer
- Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460920988
- Phone
- +1 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $999,994
- in 1 filing
- Open-market sales, last 90 days
- $39,368
- in 1 filing
Net +$960,625. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 3 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-03-10 | MCGRATH JOHN EVP & Chief Financial Officer | Sale | −24,000 | $20.00 | $480K | 126,827 |
| 2017-02-21 | MCGRATH JOHN EVP & Chief Financial Officer | Sale | −9,000 | $15.14 | $136K | 150,827 |
| 2017-02-16 | Gallagher Carol Giltner Director | Sale | −1,183 | $16.10 | $19K | 102,192 |
| 2017-02-16 | Soffer Gad EVP & Chief Strategy Officer | Sale | −7,273 | $15.62 | $114K | 269,027 |
| 2017-02-16 | Clark Mitchall G. EVP & Chief R & QA Officer | Sale | −3,059 | $15.96 | $49K | 149,661 |
| 2017-02-16 | Ciechanover Isaac E. Chief Executive Officer | Sale | −2,400 | $15.57 | $37K | 348,978 |
| 2017-02-15 | Gallagher Carol Giltner Director | Exercise or conversion | +1,548 | 102,558 | ||
| 2017-02-15 | Gallagher Carol Giltner Director | Exercise or conversion | +817 | 103,375 | ||
| 2017-02-15 | Gallagher Carol Giltner Director | Exercise or conversion · Restricted Stock Units | −1,548 | 6,194 | ||
| 2017-02-15 | Gallagher Carol Giltner Director | Exercise or conversion · Restricted Stock Units | −817 | 3,814 | ||
| 2017-02-15 | MCGRATH JOHN EVP & Chief Financial Officer | Exercise or conversion | +2,804 | 152,130 | ||
| 2017-02-15 | MCGRATH JOHN EVP & Chief Financial Officer | Exercise or conversion | +7,697 | 159,827 | ||
| 2017-02-15 | MCGRATH JOHN EVP & Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −2,804 | 935 | ||
| 2017-02-15 | MCGRATH JOHN EVP & Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −7,697 | 28,224 | ||
| 2017-02-15 | Fust Matthew K Director | Exercise or conversion | +1,603 | 20,696 | ||
| 2017-02-15 | Fust Matthew K Director | Exercise or conversion · Restricted Stock Units | −1,603 | 6,944 | ||
| 2017-02-15 | Soffer Gad EVP & Chief Strategy Officer | Exercise or conversion | +9,616 | 272,154 | ||
| 2017-02-15 | Soffer Gad EVP & Chief Strategy Officer | Exercise or conversion | +4,146 | 276,300 | ||
| 2017-02-15 | Soffer Gad EVP & Chief Strategy Officer | Exercise or conversion · Restricted Stock Units | −9,616 | 6,410 | ||
| 2017-02-15 | Soffer Gad EVP & Chief Strategy Officer | Exercise or conversion · Restricted Stock Units | −4,146 | 15,201 |
Page 46 of 71 · 1,403 trades